Inflammatory Bowel Disease

Patients with inflammatory bowel disease who responded to biologic therapy experienced improvement in sexual dysfunction, according to research presented at the ACG Annual Scientific Meeting.

In October, Boehringer Ingelheim’s adalimumab-adbm secured a landmark FDA approval as the first interchangeable biosimilar to AbbVie’s blockbuster drug, Humira — but, as rivals scramble for second place, will the designation be worth the price?

Use of a universal nutritional screening tool may help identify patients with inflammatory bowel disease who are at high risk for malnutrition and other adverse outcomes, according to data presented at the ACG Annual Scientific Meeting.

Early anti-tumor necrosis factor administration reduced late B2 development among pediatric patients with Crohn’s disease, according to a presenter.

A point-of-care intestinal ultrasound effectively assessed endoscopic disease severity through bowel wall thickness, according to a poster presentation.

Children with inflammatory bowel disease had a low risk of severe COVID-19 infection, even while taking immunosuppressants, according to a poster.

In this Healio Gastroenterology video exclusive, Miguel Regueiro, MD, FACG, discussed how anti-TNF therapy should be used as first-line therapy for treatment of inflammatory bowel disease.

In this Healio Gastroenterology video exclusive, Stephen B. Hanauer, MD, FACG, discussed intravenous iron products being used in the treatment iron deficiency anemia in patients with inflammatory bowel disease.

In this Healio Gastroenterology video exclusive, Jessica R. Allegretti, MD, MPH, director of the fecal microbiota center at Brigham and Women’s Hospital, discussed treatment options for recurrence for Clostridioides difficile infection.

Exclusive enteral nutrition intervention improved malnutrition and disease status among pediatric patients with very early-onset inflammatory bowel disease, according to a speaker.